Dr. Richard Furman Discusses Use of Ibrutinib in Treatment of CLL Patients

In this video from OncLive, Dr. Richard Furman discusses the treatment objectives he looks to achieve when treating CLL patients with ibrutinib.

Unknown's avatar

Author: lymphomaprogram

Located on the Upper East Side of New York City, the Lymphoma Program at Weill Cornell Medical College/NewYork Presbyterian Hospital is internationally recognized for our efforts to enable patients with non-Hodgkin lymphoma, Hodgkin disease and related disorders to have the best possible clinical outcome, including cure when possible.

Post a Comment